Cardinal Health (NYSE:CAH) announced its earnings results on Thursday. The company reported $1.27 EPS for the quarter, beating analysts’ consensus estimates of $1.09 by $0.18, Briefing.com reports. Cardinal Health had a return on equity of 25.96% and a net margin of 0.94%. The business had revenue of $37.34 billion during the quarter, compared to analysts’ expectations of $36.75 billion. During the same quarter in the prior year, the firm earned $1.29 earnings per share. The business’s revenue was up 6.0% compared to the same quarter last year. Cardinal Health updated its FY20 guidance to $4.85-5.10 EPS.
Shares of CAH stock traded up $0.55 during trading hours on Friday, reaching $53.75. The company had a trading volume of 3,313,580 shares, compared to its average volume of 2,953,817. The company has a debt-to-equity ratio of 1.20, a quick ratio of 0.54 and a current ratio of 1.07. The stock has a fifty day moving average of $48.75 and a 200-day moving average of $46.39. The company has a market capitalization of $15.06 billion, a price-to-earnings ratio of 10.18, a PEG ratio of 1.72 and a beta of 1.32. Cardinal Health has a 12-month low of $41.03 and a 12-month high of $58.31.
A number of equities analysts have commented on CAH shares. ValuEngine raised Cardinal Health from a “strong sell” rating to a “sell” rating in a report on Wednesday, October 2nd. JPMorgan Chase & Co. increased their target price on Cardinal Health from $51.00 to $56.00 and gave the company a “neutral” rating in a report on Friday. Morgan Stanley reduced their target price on Cardinal Health from $50.00 to $41.00 and set an “underweight” rating for the company in a report on Friday, September 6th. TheStreet cut Cardinal Health from a “c+” rating to a “d” rating in a report on Thursday. Finally, Argus cut Cardinal Health from a “buy” rating to a “hold” rating in a report on Tuesday, August 27th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and one has issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $53.89.
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.
Further Reading: Short Selling Stocks and Day Traders
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.